{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:53:05Z","timestamp":1792795985092,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007268","name":"Washington University in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.path.2020.02.006","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T17:23:50Z","timestamp":1588872230000},"page":"305-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Sellar Tumors"],"prefix":"10.1016","volume":"13","author":[{"given":"Katherine E.","family":"Schwetye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonika M.","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2020.02.006_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/jnen\/nlz040","article-title":"Pituitary adenoma in pediatric and adolescent populations","author":"Chen","year":"2019","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.path.2020.02.006_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.path.2020.02.006_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/nox158","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014","author":"Ostrom","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.path.2020.02.006_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-017-1769-8","article-title":"The 2017 World Health Organization classification of tumors of the pituitary gland: a summary","author":"Lopes","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.path.2020.02.006_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-005-1093-6","article-title":"The 2004 World Health Organization classification of pituitary tumors: what is new?","author":"Al-Shraim","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.path.2020.02.006_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2016.09.014","article-title":"Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas","author":"Zaidi","year":"2016","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.path.2020.02.006_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-013-1084-y","article-title":"A\u00a0new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up","author":"Trouillas","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.path.2020.02.006_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-015-0229-8","article-title":"Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications","author":"Miermeister","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.path.2020.02.006_bib9","doi-asserted-by":"crossref","DOI":"10.1159\/000375448","article-title":"Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis","author":"Chiloiro","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.path.2020.02.006_bib10","doi-asserted-by":"crossref","DOI":"10.1159\/000442327","article-title":"Magnetic resonance imaging of pituitary tumors","author":"Bonneville","year":"2016","journal-title":"Front Horm Res"},{"key":"10.1016\/j.path.2020.02.006_bib11","first-page":"261","article-title":"Transsphenoidal neurosurgery of intracranial neoplasm","volume":"15","author":"Hardy","year":"1976","journal-title":"Adv Neurol"},{"key":"10.1016\/j.path.2020.02.006_bib12","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"10.1016\/j.path.2020.02.006_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s10143-011-0360-3","article-title":"Cavernous sinus medial wall: dural or fibrous layer? Systematic review of the literature","author":"Gon\u00e7alves","year":"2012","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.path.2020.02.006_bib14","doi-asserted-by":"crossref","DOI":"10.1159\/000091573","article-title":"Endoscopic endonasal cavernous sinus surgery, with special reference to pituitary adenomas","author":"Frank","year":"2006","journal-title":"Front Horm Res"},{"key":"10.1016\/j.path.2020.02.006_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-015-0675-0","article-title":"Extended transsphenoidal approach for pituitary adenomas invading the cavernous sinus using multiple complementary techniques","author":"Bao","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.path.2020.02.006_bib16","article-title":"Surgical outcomes using a medial-to-lateral endonasal endoscopic approach to pituitary adenomas invading the cavernous sinus: clinical article","author":"Woodworth","year":"2014","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.path.2020.02.006_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2016.08.088","article-title":"Cavernous sinus invasion in pituitary adenomas: systematic review and pooled data meta-analysis of radiologic criteria and comparison of endoscopic and microscopic surgery","author":"Dhandapani","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.path.2020.02.006_bib18","doi-asserted-by":"crossref","DOI":"10.5858\/arpa.2016-0082-OA","article-title":"Steroidogenic factor 1, pit-1, and adrenocorticotropic hormone: a rational starting place for the immunohistochemical characterization of pituitary adenoma","author":"McDonald","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2020.02.006_bib19","series-title":"Pathology and genetics of tumours of endocrine organs","author":"Lloyd","year":"2017"},{"key":"10.1016\/j.path.2020.02.006_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s12022-008-9029-z","article-title":"Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form","author":"Obari","year":"2008","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2020.02.006_bib21","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2014-2468","article-title":"A\u00a0structural and functional acromegaly classification","author":"Cuevas-Ramos","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2020.02.006_bib22","doi-asserted-by":"crossref","DOI":"10.1210\/jcem.86.9.7819","article-title":"Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria","author":"Kreutzer","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.path.2020.02.006_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/eje.1.02326","article-title":"Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry","volume":"156","author":"Saeger","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.path.2020.02.006_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-005-1111-8","article-title":"Morphologic changes of prolactin-producing pituitary adenomas after short treatment with dopamine agonists","author":"Kontogeorgos","year":"2006","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.path.2020.02.006_bib25","first-page":"135","article-title":"Light microscopical morphometry of prolactin secreting adenomas under treatment with dopamine agonists","volume":"2","author":"Hamester","year":"1987","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.path.2020.02.006_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41379-018-0016-8","article-title":"Epidemiology and biomarker profile of pituitary adenohypophysial tumors","author":"Mete","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2020.02.006_bib27","article-title":"Thyroid-stimulating hormone pituitary adenomas","author":"Clarke","year":"2008","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.path.2020.02.006_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.2015.151","article-title":"Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas","author":"Mete","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2020.02.006_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000000806","article-title":"Mixed gangliocytoma-pituitary adenoma. Insights on the pathogenesis of a rare sellar tumor","author":"Lopes","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2020.02.006_bib30","doi-asserted-by":"crossref","DOI":"10.3803\/EnM.2013.28.4.245","article-title":"The molecular pathogenesis of pituitary adenomas: an update","author":"Jiang","year":"2013","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.path.2020.02.006_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.nec.2019.05.001","article-title":"Molecular biology of pituitary adenomas","author":"Faltermeier","year":"2019","journal-title":"Neurosurg Clin N Am"},{"key":"10.1016\/j.path.2020.02.006_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-018-0811-0","article-title":"Genomic alterations in sporadic pituitary tumors","author":"Bi","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.path.2020.02.006_bib33","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-15-0320","article-title":"Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients","author":"Rostomyan","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.path.2020.02.006_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ando.2017.04.012","article-title":"AIP mutations and gigantism","author":"Rostomyan","year":"2017","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.path.2020.02.006_bib35","article-title":"Gigantism, acromegaly, and GPR101 mutations","author":"Roohi","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2020.02.006_bib36","series-title":"GeneReviews\u00ae [Internet]","article-title":"DICER1-related disorders","author":"Doros","year":"2014"},{"key":"10.1016\/j.path.2020.02.006_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/cen.13063","article-title":"Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review","author":"Joshi","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.path.2020.02.006_bib38","article-title":"New molecular, biological, and immunological agents inducing hypophysitis","author":"Angelousi","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.path.2020.02.006_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00083","article-title":"Hypophysitis following treatment with Ustekinumab: radiological and pathological findings","author":"Ramos-Lev\u00ed","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.path.2020.02.006_bib40","first-page":"390","article-title":"The management of hypophysitis","volume":"41","author":"Karaca","year":"2016","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.path.2020.02.006_bib41","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-17-0009","article-title":"Hypophysitis: diagnosis and treatment","author":"Joshi","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.path.2020.02.006_bib42","article-title":"Lymphocytic hypophysitis successfully treated with stereotactic radiosurgery: case report and review of the literature","author":"Pekic","year":"2018","journal-title":"J\u00a0Neurol Surg A Cent Eur Neurosurg"},{"key":"10.1016\/j.path.2020.02.006_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-016-0773-7","article-title":"Critical review of IgG4-related hypophysitis","author":"Shikuma","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.path.2020.02.006_bib44","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-017-0852-4","article-title":"A\u00a0case series of atypical features of patients with biopsy-proven isolated IgG4-related hypophysitis and normal serum IgG4 levels","author":"Yuen","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.path.2020.02.006_bib45","article-title":"Comprehensive diagnostic criteria for IgG4- related disease ( IgG4-RD ), 2011 comprehensive diagnostic criteria for IgG4-related disease","author":"Rheumatology","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.path.2020.02.006_bib46","doi-asserted-by":"crossref","DOI":"10.1080\/14397595.2017.1290911","article-title":"Current approach to the diagnosis of IgG4-related disease\u2013Combination of comprehensive diagnostic and organ-specific criteria","author":"Umehara","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.path.2020.02.006_bib47","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-010-0746-2","article-title":"IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria","author":"Lindstrom","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.path.2020.02.006_bib48","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2010-2970","article-title":"IgG4-related hypophysitis: a new addition to the hypophysitis spectrum","author":"Leporati","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2020.02.006_bib49","doi-asserted-by":"crossref","DOI":"10.1097\/00004728-199511000-00003","article-title":"Rathke cleft cyst: Ct, mr, and pathology of 23 cases","author":"Naylor","year":"1995","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.path.2020.02.006_bib50","doi-asserted-by":"crossref","DOI":"10.1007\/s00701-007-1234-x","article-title":"Rathke\u2019s cleft cysts: differentiation from other cystic lesions in the pituitary fossa by use of single-shot fast spin-echo diffusion-weighted MR imaging","author":"Kunii","year":"2007","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.path.2020.02.006_bib51","doi-asserted-by":"crossref","DOI":"10.1007\/s12022-017-9471-x","article-title":"Xanthomatous hypophysitis is associated with ruptured Rathke\u2019s Cleft cyst","author":"Duan","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.path.2020.02.006_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/s10143-008-0120-1","article-title":"Rathke\u2019s cleft cyst rupture as potential initial event of a secondary perifocal lymphocytic hypophysitis: proposal of an unusual pathogenetic event and review of the literature","author":"Schittenhelm","year":"2008","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.path.2020.02.006_bib53","article-title":"Lymphocytic hypophysitis secondary to ruptured Rathke Cleft cyst: case report and literature review","author":"Yang","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.path.2020.02.006_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/0090-3019(95)00144-1","article-title":"The pathologic, surgical, and MR spectrum of Rathke cleft cysts","author":"Kleinschmidt-DeMasters","year":"1995","journal-title":"Surg Neurol"},{"key":"10.1016\/j.path.2020.02.006_bib55","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-014-1270-6","article-title":"BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma","author":"Larkin","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.path.2020.02.006_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.oooo.2018.11.004","article-title":"Craniopharyngiomas and odontogenic tumors mimic normal odontogenesis and share genetic mutations, histopathologic features, and molecular pathways activation","author":"Gomes","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.path.2020.02.006_bib57","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-013-0465-5","article-title":"Mixed pituitary adenoma\/craniopharyngioma: clinical, morphological, immunohistochemical and ultrastructural study of a case, review of the literature, and pathogenetic and nosological considerations","author":"Finzi","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.path.2020.02.006_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2018.10.048","article-title":"Pituitary adenoma and craniopharyngioma collision tumor: diagnostic, treatment considerations, and review of the literature","author":"Snyder","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.path.2020.02.006_bib59","doi-asserted-by":"crossref","DOI":"10.1097\/MOP.0b013e3282495a22","article-title":"Craniopharyngioma: modern concepts in pathogenesis and treatment","author":"Garr\u00e8","year":"2007","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"10.1016\/j.path.2020.02.006_bib60","first-page":"25","article-title":"Ciliated craniopharyngioma may arise from Rathke cleft cyst","volume":"25","author":"Sato","year":"2006","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.path.2020.02.006_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9440(10)64477-X","article-title":"Craniopharyngiomas of adamantinomatous type harbor \u03b2-Catenin gene mutations","author":"Sekine","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.path.2020.02.006_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/ng.2868","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","author":"Brastianos","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.path.2020.02.006_bib63","article-title":"Intracystic bleomycin for cystic craniopharyngiomas in children","author":"Zhang","year":"2016","journal-title":"CochraneDatabase Syst Rev"},{"key":"10.1016\/j.path.2020.02.006_bib64","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-016-0287-6","article-title":"Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles","author":"H\u00f6lsken","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.path.2020.02.006_bib65","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.74.2.260","article-title":"Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas","author":"Rickert","year":"2003","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1 Suppl","key":"10.1016\/j.path.2020.02.006_bib66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3171\/ped.2004.101.2.0085","article-title":"Comparative genomic hybridization analysis of pediatric adamantinomatous craniopharyngiomas and a review of the literature","volume":"101","author":"Yoshimoto","year":"2004","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.path.2020.02.006_bib67","doi-asserted-by":"crossref","DOI":"10.1007\/s11154-019-09484-1","article-title":"Primary tumors of the posterior pituitary: a systematic review","author":"Guerrero-P\u00e9rez","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.path.2020.02.006_bib68","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2003-030395","article-title":"Tumors metastatic to the pituitary gland: case report and literature review","author":"Komninos","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2020.02.006_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2004.03.006","article-title":"Intrasellar and parasellar cellular schwannoma","author":"Perez","year":"2004","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.path.2020.02.006_bib70","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002931","article-title":"Schwannoma in sellar region mimics invasive pituitary macroadenoma: literature review with one case report","author":"Kong","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.path.2020.02.006_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2016.08.128","article-title":"Intrasellar and Suprasellar Schwannoma misdiagnosed as pituitary macroadenoma: a case report and review of the literature","author":"Zhang","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.path.2020.02.006_bib72","article-title":"Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas","author":"Tzortzidis","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.path.2020.02.006_bib73","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.12-11-1344","article-title":"Chordoma: the nonsarcoma primary bone tumor","author":"Chugh","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.path.2020.02.006_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.otc.2015.09.004","article-title":"Sellar lesions\/pathology","author":"Bresson","year":"2016","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.path.2020.02.006_bib75","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A3333","article-title":"Diffusion-weighted MRI: distinction of skull base chordoma from chondrosarcoma","author":"Yeom","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.path.2020.02.006_bib76","doi-asserted-by":"crossref","DOI":"10.1007\/s40134-018-0275-7","article-title":"State-of-the-art imaging in human chordoma of the skull base","author":"Santegoeds","year":"2018","journal-title":"Curr Radiol Rep"},{"key":"10.1016\/j.path.2020.02.006_bib77","article-title":"Chordoma of the head and neck: a review","author":"Wasserman","year":"2018","journal-title":"HeadNeck Pathol"},{"key":"10.1016\/j.path.2020.02.006_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.2008.144","article-title":"Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis","author":"Oakley","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2020.02.006_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2017.10.010","article-title":"Prognostic factors in skull base chordoma: a systematic literature review and meta-analysis","author":"Zou","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.path.2020.02.006_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2019.06.004","article-title":"Comprehensive review of cranial chordomas using national databases in the USA","author":"Hulou","year":"2019","journal-title":"Clin Oncol"},{"key":"10.1016\/j.path.2020.02.006_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00567","article-title":"A\u00a0systematic review of atypical teratoid rhabdoid tumor in adults","author":"Chan","year":"2018","journal-title":"Front Oncol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187591812030012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187591812030012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:39:41Z","timestamp":1761748781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187591812030012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S187591812030012X"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2020.02.006","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sellar Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2020.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}